A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2011
12/13/2011	US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/13/2011	US8075914 Controlled release melatonin
12/13/2011	US8075911 Transparent transdermal nicotine delivery devices
12/13/2011	CA2576647C Vla-4 antagonists
12/13/2011	CA2539070C Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/13/2011	CA2502528C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/08/2011	WO2011153502A2 Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
12/08/2011	WO2011153157A2 Benzoquinolone inhibitors of vmat2
12/08/2011	WO2011152657A2 Acetyl-l-carnitine malate, process for preparing the same, and pharmaceutical composition comprising the same
12/08/2011	WO2011152524A1 Cell growth-promoting peptide and use thereof
12/08/2011	WO2011152508A1 Optically active dibenzylamine derivative, and manufacturing method for same
12/08/2011	WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	WO2011152485A1 Novel 4,5-fused pyrimidine derivative
12/08/2011	WO2011152411A1 Crystal of thienopyrimidine derivative
12/08/2011	WO2011152330A1 Soybean protein hydrolysate-containing antioxidant and use thereof
12/08/2011	WO2011152297A1 Solid dispersion comprising triazole compound
12/08/2011	WO2011152007A1 Sympathetic nerve depressant, skin temperature reducing agent, and cosmetic composition, food, and sundry items containing said depressant or agent
12/08/2011	WO2011152005A1 Sympatholytic agent, and cosmetic, food and sundry containing same
12/08/2011	WO2011151808A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
12/08/2011	WO2011151807A1 Conjugates for the prevention or treatment of nicotine addiction
12/08/2011	WO2011151551A1 Xenon-based inhalable drug for preventing addiction relapses in humans
12/08/2011	WO2011151361A1 Novel compounds
12/08/2011	WO2011151359A1 Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
12/08/2011	WO2011151251A1 New ccr2 antagonists
12/08/2011	WO2011151076A2 MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS
12/08/2011	WO2011125070A3 Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
12/08/2011	WO2011098689A3 Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (ocd)
12/08/2011	WO2011076421A3 Compositions comprising venlafaxine and celecoxib in the treatment of pain
12/08/2011	US20110301244 Fast acting naratriptan composition
12/08/2011	US20110301243 Novel method
12/08/2011	US20110301238 Seizure related disorders and therapeutic methods thereof
12/08/2011	US20110301235 Organoselenium compounds and uses thereof
12/08/2011	US20110301234 Formulations of ladostigil tartrate
12/08/2011	US20110301217 Selective Glycosidase Inhibitors and Uses Thereof
12/08/2011	US20110301215 Inhibitors of plasma kallikrein
12/08/2011	US20110301214 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
12/08/2011	US20110301210 Use of pramipexole to treat amyotrophic lateral sclerosis
12/08/2011	US20110301204 Administration regime for nitrocatechols
12/08/2011	US20110301203 Chemical compounds
12/08/2011	US20110301191 Methods of treatment using selective 5-ht2a inverse agonists
12/08/2011	US20110301190 Polymorphic forms of a gabaa agonist
12/08/2011	US20110301167 PYRAZOLO [4,3-c] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301157 Bicyclic amides as kinase inhibitors
12/08/2011	US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011	US20110301150 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
12/08/2011	US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011	US20110301147 Modified release preparations containing oxcarbazepine and derivatives thereof
12/08/2011	US20110301146 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
12/08/2011	US20110301141 Aminopyrimidine derivatives as lrrk2 inhibitors
12/08/2011	US20110301140 Pyridine Carboxamide orexin Receptor Antagonists
12/08/2011	US20110301133 Compositions of protein receptor tyrosine kinase inhibitors
12/08/2011	US20110301131 Drug Delivery Implants and Processes for Their Preparation
12/08/2011	US20110301128 Pyrrole Derivatives As Pharmaceutical Agents
12/08/2011	US20110301121 Hydrogel of polysaccharide derivative
12/08/2011	US20110301112 Fused ring thrombin receptor antagonists
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301087 Crf1 receptor compounds
12/08/2011	US20110300533 Yeast Screens for Treatment of Human Disease
12/08/2011	US20110300240 Cajanus extracts and glucosamine for inflammatory disorders
12/08/2011	US20110300237 Protective solutions for organs
12/08/2011	US20110300217 Hydromorphone therapy
12/08/2011	US20110300213 Oral formulations of bipolar trans carotenoids
12/08/2011	US20110300207 Method of treating post-surgical acute pain
12/08/2011	US20110300190 Compound, composition and uses thereof
12/08/2011	US20110300174 Conjugates for the prevention or treatment of nicotine addiction
12/08/2011	US20110300167 Cxcr5 receptor compounds
12/08/2011	US20110300165 Substituted isoxazole compounds
12/08/2011	US20110300157 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/08/2011	US20110300149 Ljungan virus
12/08/2011	US20110300145 Interferon Alpha Antibodies And Their Uses
12/08/2011	US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/08/2011	US20110300141 Novel Alphabeta-Binding protein and its peptide derivatives and uses thereof
12/08/2011	US20110300136 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
12/08/2011	US20110300135 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/08/2011	US20110300119 Methods of enriching and using regulatory t cells
12/08/2011	US20110300114 METHOD OF CELL CULTURE AND METHOD OF TREATMENT COMPRISING A vEPO PROTEIN VARIANT
12/08/2011	US20110300113 Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro
12/08/2011	US20110300081 Orosoluble and/or effervescent compositions containing at least a salt of s-adenosyl methionine (same)
12/08/2011	US20110300077 Human Anti-Alpha-Synuclein Antibodies
12/08/2011	US20110300075 Method of Risk Management for Patients Undergoing Natalizumab Treatment
12/08/2011	US20110300074 3,6-disubstituted xanthylium salts
12/08/2011	CA2801509A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	CA2801417A1 Optically active dibenzylamine derivative, and method for preparing thereof
12/08/2011	CA2801405A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
12/08/2011	CA2801061A1 Benzoquinolone inhibitors of vmat2
12/08/2011	CA2801030A1 Crystal of thienopyrimidine derivative
12/08/2011	CA2800882A1 Conjugates for the prevention or treatment of nicotine addiction
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP2392573A1 Quinoline derivative
12/07/2011	EP2392572A1 Substituted diazepan compounds as orexin receptor antagonists
12/07/2011	EP2392344A1 Suture line administration technique using botulinum toxins
12/07/2011	EP2392320A1 Treatment of inflammatory diseases
12/07/2011	EP2391628A1 2-aza-bicycloý2.2.1¨heptane compounds and uses thereof
12/07/2011	EP2391625A1 New adenosine receptor ligands and uses thereof
12/07/2011	EP2391621A2 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
12/07/2011	EP2391618A2 Cromolyn derivatives and related methods of imaging and treatment
12/07/2011	EP2391617A1 Azetidines as histamine h3 receptor antagonists
12/07/2011	EP2391615A1 Piperidine derivatives as nk3 receptor antagonists

1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 1833